Nancy De Nève

1.2k total citations
31 papers, 961 citations indexed

About

Nancy De Nève is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Nancy De Nève has authored 31 papers receiving a total of 961 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Nancy De Nève's work include Cancer Genomics and Diagnostics (6 papers), Phytochemistry and Bioactive Compounds (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Nancy De Nève is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Phytochemistry and Bioactive Compounds (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Nancy De Nève collaborates with scholars based in Belgium, United States and Czechia. Nancy De Nève's co-authors include Róbert Kiss, Véronique Mathieu, Marie Le Mercier, Tatjana Mijatovic, Isabelle Salmon, Christine Decaestecker, Florence Lefranc, Jean‐François Gaussin, Nicky D’Haene and Janique Dewelle and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Nancy De Nève

30 papers receiving 944 citations

Peers

Nancy De Nève
Melyssa R. Bratton United States
Hong Zheng China
Yufeng Shi China
Celia Garcı́a-Prieto United States
Caiyu Lin China
Sébastien Sauvage Belgium
Sung Hee Hong South Korea
Md Kamrul Hasan United States
Melyssa R. Bratton United States
Nancy De Nève
Citations per year, relative to Nancy De Nève Nancy De Nève (= 1×) peers Melyssa R. Bratton

Countries citing papers authored by Nancy De Nève

Since Specialization
Citations

This map shows the geographic impact of Nancy De Nève's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy De Nève with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy De Nève more than expected).

Fields of papers citing papers by Nancy De Nève

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy De Nève. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy De Nève. The network helps show where Nancy De Nève may publish in the future.

Co-authorship network of co-authors of Nancy De Nève

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy De Nève. A scholar is included among the top collaborators of Nancy De Nève based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy De Nève. Nancy De Nève is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Racu, Marie-Lucie, Andréa Alex Schiavo, Claude Van Campenhout, et al.. (2024). Validation of a targeted next-generation sequencing panel for pancreatic ductal adenocarcinomas. Experimental and Molecular Pathology. 139. 104920–104920. 1 indexed citations
2.
Demols, Anne, Nancy De Nève, Claude Van Campenhout, et al.. (2023). A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas. The Oncologist. 28(7). e520–e525. 11 indexed citations
3.
Lebrun, Laetitia, Bárbara Meléndez, Nancy De Nève, et al.. (2020). Clinical, radiological and molecular characterization of intramedullary astrocytomas. Acta Neuropathologica Communications. 8(1). 128–128. 19 indexed citations
4.
Demols, Anne, Nancy De Nève, Claude Van Campenhout, et al.. (2020). O-4 NTRK gene fusions in bilio-pancreatic cancers. Annals of Oncology. 31. 233–233. 7 indexed citations
5.
D’Haene, Nicky, Bárbara Meléndez, Nancy De Nève, et al.. (2019). Design and Validation of a Gene-Targeted, Next-Generation Sequencing Panel for Routine Diagnosis in Gliomas. Cancers. 11(6). 773–773. 20 indexed citations
6.
Mercier, Marie Le, Nancy De Nève, Monique Delos, et al.. (2016). O-018 Clinical application of targeted next generation sequencing for colorectal cancer patients: a multicentric Belgian experience. Annals of Oncology. 27. ii124–ii124. 1 indexed citations
7.
D’Haene, Nicky, Marie Le Mercier, Nancy De Nève, et al.. (2015). Clinical Validation of Targeted Next Generation Sequencing for Colon and Lung Cancers. PLoS ONE. 10(9). e0138245–e0138245. 67 indexed citations
8.
Mercier, Marie Le, Nancy De Nève, Thierry Roumeguère, et al.. (2015). Diagnostic value of the UCA1 test for bladder cancer detection: a clinical study. SpringerPlus. 4(1). 349–349. 30 indexed citations
9.
Mercier, Marie Le, et al.. (2014). Next‐generation sequencing improves the diagnosis of thyroid FNA specimens with indeterminate cytology. Histopathology. 66(2). 215–224. 67 indexed citations
10.
Mercier, Marie Le, Xavier Moles Lopez, Nancy De Nève, et al.. (2012). A Simplified Approach for the Molecular Classification of Glioblastomas. PLoS ONE. 7(9). e45475–e45475. 48 indexed citations
11.
Mijatovic, Tatjana, Tina Mahieu, Céline Bruyère, et al.. (2008). UNBS5162, a Novel Naphthalimide That Decreases CXCL Chemokine Expression in Experimental Prostate Cancers. Neoplasia. 10(6). 573–586. 46 indexed citations
12.
Gnoula, Charlemagne, Véronique Mégalizzi, Nancy De Nève, et al.. (2008). Balanitin-6 and -7: Diosgenyl saponins isolated from Balanites aegyptiaca Del. display significant anti-tumor activity in vitro and in vivo. International Journal of Oncology. 61 indexed citations
13.
Mathieu, Véronique, Nancy De Nève, Marie Le Mercier, et al.. (2008). Combining Bevacizumab with Temozolomide Increases the Antitumor Efficacy of Temozolomide in a Human Glioblastoma Orthotopic Xenograft Model. Neoplasia. 10(12). 1383–1392. 101 indexed citations
14.
Mijatovic, Tatjana, Nancy De Nève, Véronique Mathieu, & Róbert Kiss. (2008). c-Myc down-regulation as a surrogate marker of cardenolide-induced anti-tumor activity.. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 1 indexed citations
15.
Mijatovic, Tatjana, Nancy De Nève, Véronique Mathieu, et al.. (2007). UNBS1450-mediated cMyc down-regulation and nucleolar targeting in carcinoma cells through over-expressed sodium pump alpha-1 subunit.. Molecular Cancer Therapeutics. 6. 1 indexed citations
16.
Mijatovic, Tatjana, Philippe Gailly, Véronique Mathieu, et al.. (2007). Neurotensin is a Versatile Modulator of In Vitro Human Pancreatic Ductal Adenocarcinoma Cell (PDAC) Migration. Analytical Cellular Pathology. 29(4). 315–326. 35 indexed citations
17.
18.
Mijatovic, Tatjana, Véronique Mathieu, Nancy De Nève, et al.. (2006). Cardenolide-mediated nucleolar disorganisation contributes therapeutic benefits in subcutaneous and orthotopic xenograft models of human refractory prostate cancers.. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 2 indexed citations
19.
Mijatovic, Tatjana, Véronique Mathieu, Jean‐François Gaussin, et al.. (2006). Cardenolide-Induced Lysosomal Membrane Permeabilization Demonstrates Therapeutic Benefits in Experimental Human Non-Small Cell Lung Cancers. Neoplasia. 8(5). 402–412. 118 indexed citations
20.
Nève, Nancy De, Arsène Burny, Stéphane Bach, et al.. (2003). Expression in a RabGAP yeast mutant of two human homologues, one of which is an oncogene. Biochemical and Biophysical Research Communications. 310(2). 498–504. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melyssa R. Bratton Breakdown of academic impact, for papers by Hong Zheng Breakdown of academic impact, for papers by Yufeng Shi Breakdown of academic impact, for papers by Celia Garcı́a-Prieto Breakdown of academic impact, for papers by Caiyu Lin Breakdown of academic impact, for papers by Sébastien Sauvage Breakdown of academic impact, for papers by Sung Hee Hong Breakdown of academic impact, for papers by Md Kamrul Hasan
Rankless by CCL
2026